Explain Cost Effectiveness of the Health System Efficiency Flashcards

Is a step beyond the determination of efficacy. Whereas efficacy is concerned only with the benefit to be derived from the use of technology, cost-effectiveness weighs benefits against costs. Health care is cost-effective when benefits exceed the costs.

Are computer-based information and analytical tools to support managerial decision making in health care organizations.

Refers to the health benefit to be derived from the use of technology.

Information technology applications that are designed to improve clinical efficiency, accuracy, and reliability.

Improved benefits at lower costs.

The use of advanced telecommunications, such as videoconferencing and computer technology, to provide health care at a distance.

Is the proliferation of technology once it is developed.

Are systematically developed protocols to assist practitioners in delivering appropriate health care for specific clinical conditions.

Refers to the overall satisfaction with life during and after medical treatment.

Implies the use of technology without cost considerations, especially when the benefits to be derived from the use of technology are small compared to the costs.

Refers to the evaluation of medical technology to determine its efficacy, safety, and cost-effectiveness.

This is any scientific discovery that finds its application in delivering health care. • It results from the application of scientific knowledge produced by biomedical research • It adapts certain developments from other scientific fields, such as chemistry, physics, engineering, etc.

The Health Insurance Portability and Accountability Act (HIPAA) was enacted in 1996 to address confidentiality of patient information and to confer certain patient rights with regard to information contained in their medical records.

Ensure the safety and effectiveness of drugs and medical devices and control access by deciding which drugs need prescriptions and which ones can be obtained over the counter. Legislation in place today requires the FDA to review the safety and effectiveness of a new drug before it is marketed. The Orphan Drug Act provides incentives, such as grant funding, to develop new drugs for rare diseases.

• Class I: require general controls regarding misbranding (fraudulent claims) • Class II: devices are subject to certain performance standards • Class III: premarket approval regarding safety and effectiveness is required